New study aims to Fine-Tune radiation for liver cancer spread
NCT ID NCT04668872
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how Y90 radioembolization, a radiation treatment for liver tumors that have spread from colorectal cancer, actually works inside the body. Researchers will collect small tissue samples (biopsies) from the liver after treatment to see how much tumor damage occurs based on the radiation dose given. The goal is to better understand the treatment's effects, which could help doctors improve how they deliver radiation in the future. About 80 adults with colorectal cancer that has spread to the liver and cannot be surgically removed will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Yttrium-90 (Y90) radiation delivered via transarterial radioembolization (TARE)
- What this could lead to
- If successful, this study could improve how doctors plan Y90 radioembolization for liver metastases, potentially making treatment more effective.
- What could go wrong
- This is a small, early feasibility study focused on gathering data, not testing a new treatment. It may not lead to immediate changes in patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA OF THE COLON are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Digital nurse companion: could an app ease the burden of chronic illness?
- Can we predict chemo brain before it happens?
- Can targeted liver chemo turn inoperable tumors into operable ones?
- Your gut bacteria might reveal hidden cancer risk